HK1010116A1 - Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising them - Google Patents
Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising themInfo
- Publication number
- HK1010116A1 HK1010116A1 HK98110940A HK98110940A HK1010116A1 HK 1010116 A1 HK1010116 A1 HK 1010116A1 HK 98110940 A HK98110940 A HK 98110940A HK 98110940 A HK98110940 A HK 98110940A HK 1010116 A1 HK1010116 A1 HK 1010116A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- pharmaceutical compositions
- naphthalene derivatives
- intermediates therefor
- derivatives process
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000002790 naphthalenes Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14928895 | 1995-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1010116A1 true HK1010116A1 (en) | 1999-06-11 |
Family
ID=15471914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98110940A HK1010116A1 (en) | 1995-06-15 | 1998-09-24 | Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising them |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6005106A (hu) |
| EP (1) | EP0748805B1 (hu) |
| KR (1) | KR100435247B1 (hu) |
| CN (1) | CN1063748C (hu) |
| AR (1) | AR002483A1 (hu) |
| AT (1) | ATE164843T1 (hu) |
| AU (1) | AU706156B2 (hu) |
| BG (1) | BG62521B1 (hu) |
| BR (1) | BR9602802A (hu) |
| CA (1) | CA2178974C (hu) |
| DE (1) | DE69600221T2 (hu) |
| ES (1) | ES2116131T3 (hu) |
| HK (1) | HK1010116A1 (hu) |
| HU (1) | HU222340B1 (hu) |
| IL (1) | IL118469A (hu) |
| MY (1) | MY121606A (hu) |
| NO (1) | NO310109B1 (hu) |
| RU (1) | RU2129120C1 (hu) |
| SG (1) | SG47152A1 (hu) |
| TW (1) | TW349098B (hu) |
| ZA (1) | ZA964652B (hu) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
| JPH1171351A (ja) * | 1997-08-29 | 1999-03-16 | Ss Pharmaceut Co Ltd | 置換キノロン誘導体及びこれを含有する医薬 |
| DE69939629D1 (de) | 1998-05-05 | 2008-11-06 | Massachusetts Inst Technology | Emittierende Polymere und Vorrichtungen diese Polymere enthaltend |
| US20050147534A1 (en) | 1998-05-05 | 2005-07-07 | Massachusetts Institute Of Technology | Emissive sensors and devices incorporating these sensors |
| PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
| KR20040007596A (ko) * | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 골절 치료 촉진용 조성물 |
| CA2447618A1 (en) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for regenerative treatment of cartilage disease |
| TWI221838B (en) | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
| CA2468544A1 (en) * | 2001-12-10 | 2003-06-19 | Amgen Inc. | Vanilloid receptor ligands |
| WO2003057689A1 (en) * | 2002-01-02 | 2003-07-17 | Fujisawa Pharmaceutical Co., Ltd. | Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
| PL375552A1 (en) * | 2002-05-22 | 2005-11-28 | Amgen Inc. | Vanilloid receptor ligands and their medical applications |
| WO2004014871A1 (en) * | 2002-08-08 | 2004-02-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| EP1604981A4 (en) | 2003-03-14 | 2008-12-24 | Ono Pharmaceutical Co | NITROGENIC HETEROCYCLIC DERIVATIVES AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE |
| MXPA05010373A (es) | 2003-04-01 | 2005-12-05 | Applied Research Systems | Inhibidores de fosfodiesterasas en infertilidad. |
| JP2007516095A (ja) * | 2003-05-16 | 2007-06-21 | ユニヴァーシティ・オヴ・シカゴ | 光学分別装置および光学分別方法 |
| AU2004278382B2 (en) * | 2003-09-30 | 2008-09-18 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| EP1745034A1 (en) * | 2004-02-11 | 2007-01-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| MY139645A (en) * | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
| NZ553696A (en) | 2004-09-13 | 2010-02-26 | Ono Pharmaceutical Co | Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| WO2006034081A2 (en) | 2004-09-17 | 2006-03-30 | Massachusetts Institute Of Technology | Polymers for analyte detection |
| TWI339578B (en) | 2004-10-29 | 2011-04-01 | Mitsubishi Tanabe Pharma Corp | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| WO2006089311A1 (en) * | 2005-02-15 | 2006-08-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2006113769A1 (en) * | 2005-04-15 | 2006-10-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| US7972836B2 (en) | 2005-10-04 | 2011-07-05 | Mitsubishi Tanabe Pharma Corporation | Method of enzymatic optical resolution of racemic 4-hydroxy-1,2,3,4-tetrahydroquinoline |
| PT1944291E (pt) | 2005-10-04 | 2012-08-10 | Mitsubishi Tanabe Pharma Corp | Álcool cíclico opticamente activo e método para a sua produção |
| EP1941881B1 (en) * | 2005-10-05 | 2014-08-13 | Mitsubishi Tanabe Pharma Corporation | Naphthalene derivatives for the treatment of dermatitis and psoriasis |
| EA200870344A1 (ru) | 2006-03-10 | 2009-04-28 | Оно Фармасьютикал Ко., Лтд. | Азотсодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента |
| WO2007112347A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| WO2008042289A2 (en) | 2006-09-29 | 2008-04-10 | Massachusetts Institute Of Technology | Polymer synthetic technique |
| US8802447B2 (en) | 2006-10-05 | 2014-08-12 | Massachusetts Institute Of Technology | Emissive compositions with internal standard and related techniques |
| US20090215189A1 (en) | 2006-10-27 | 2009-08-27 | Massachusetts Institute Of Technology | Sensor of species including toxins and chemical warfare agents |
| EP1958947A1 (en) * | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
| JP2010524857A (ja) * | 2007-04-10 | 2010-07-22 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | フェン−ナフタレン及びフェン−キノリン誘導体、及びアミロイドプラークに結合させ、そして造影するための使用 |
| US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
| ES2659458T3 (es) * | 2011-06-28 | 2018-03-15 | Mitsubishi Tanabe Pharma Corporation | Compuestos de naftaleno para tratar el prurito |
| EP2749558A4 (en) | 2011-08-25 | 2014-11-19 | Mitsubishi Tanabe Pharma Corp | PROCESS FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND |
| US11970440B1 (en) | 2023-10-30 | 2024-04-30 | King Faisal University | 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
| US11932593B1 (en) | 2023-10-31 | 2024-03-19 | King Faisal University | 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
| US11987543B1 (en) | 2023-10-31 | 2024-05-21 | King Faisal University | 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3042156B2 (ja) * | 1992-02-20 | 2000-05-15 | 田辺製薬株式会社 | ナフタレン誘導体、その製法及びその合成中間体 |
| US5342841A (en) * | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
| EP0731084B1 (de) * | 1995-03-03 | 2002-09-25 | Rolic AG | Photovernetzbare Naphthylderivate |
-
1996
- 1996-05-30 IL IL11846996A patent/IL118469A/xx not_active IP Right Cessation
- 1996-05-31 TW TW085106502A patent/TW349098B/zh not_active IP Right Cessation
- 1996-06-03 MY MYPI96002135A patent/MY121606A/en unknown
- 1996-06-04 AT AT96304033T patent/ATE164843T1/de active
- 1996-06-04 AU AU54693/96A patent/AU706156B2/en not_active Expired
- 1996-06-04 DE DE69600221T patent/DE69600221T2/de not_active Expired - Lifetime
- 1996-06-04 EP EP96304033A patent/EP0748805B1/en not_active Expired - Lifetime
- 1996-06-04 ES ES96304033T patent/ES2116131T3/es not_active Expired - Lifetime
- 1996-06-11 SG SG1996010041A patent/SG47152A1/en unknown
- 1996-06-12 BG BG100656A patent/BG62521B1/bg unknown
- 1996-06-14 RU RU96112130A patent/RU2129120C1/ru active
- 1996-06-14 AR ARP960103158A patent/AR002483A1/es not_active Application Discontinuation
- 1996-06-14 CA CA002178974A patent/CA2178974C/en not_active Expired - Lifetime
- 1996-06-14 NO NO962527A patent/NO310109B1/no not_active IP Right Cessation
- 1996-06-14 BR BRPI9602802-5A patent/BR9602802A/pt not_active IP Right Cessation
- 1996-06-14 US US08/663,991 patent/US6005106A/en not_active Expired - Lifetime
- 1996-06-14 HU HU9601652A patent/HU222340B1/hu active IP Right Grant
- 1996-06-15 KR KR1019960021677A patent/KR100435247B1/ko active IP Right Grant
- 1996-06-15 ZA ZA964652A patent/ZA964652B/xx unknown
- 1996-06-17 CN CN96106608A patent/CN1063748C/zh not_active Expired - Lifetime
-
1998
- 1998-07-02 US US09/109,099 patent/US5969140A/en not_active Expired - Lifetime
- 1998-09-24 HK HK98110940A patent/HK1010116A1/xx not_active IP Right Cessation
- 1998-12-01 US US09/201,820 patent/US6214996B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR100435247B1 (ko) | 2004-09-10 |
| BG100656A (en) | 1997-09-30 |
| CA2178974C (en) | 2006-06-06 |
| ES2116131T3 (es) | 1998-07-01 |
| SG47152A1 (en) | 1998-03-20 |
| HU222340B1 (hu) | 2003-06-28 |
| CN1063748C (zh) | 2001-03-28 |
| AU706156B2 (en) | 1999-06-10 |
| EP0748805B1 (en) | 1998-04-08 |
| CA2178974A1 (en) | 1996-12-16 |
| HUP9601652A1 (en) | 1997-09-29 |
| US6005106A (en) | 1999-12-21 |
| BR9602802A (pt) | 1998-10-06 |
| ZA964652B (en) | 1996-12-12 |
| US6214996B1 (en) | 2001-04-10 |
| ATE164843T1 (de) | 1998-04-15 |
| DE69600221D1 (de) | 1998-05-14 |
| AR002483A1 (es) | 1998-03-25 |
| NO310109B1 (no) | 2001-05-21 |
| CN1142497A (zh) | 1997-02-12 |
| HU9601652D0 (en) | 1996-08-28 |
| EP0748805A1 (en) | 1996-12-18 |
| DE69600221T2 (de) | 1998-08-06 |
| MY121606A (en) | 2006-02-28 |
| BG62521B1 (bg) | 2000-01-31 |
| NO962527L (no) | 1996-12-16 |
| US5969140A (en) | 1999-10-19 |
| RU2129120C1 (ru) | 1999-04-20 |
| IL118469A (en) | 2000-08-13 |
| IL118469A0 (en) | 1996-09-12 |
| KR970001343A (ko) | 1997-01-24 |
| NO962527D0 (no) | 1996-06-14 |
| TW349098B (en) | 1999-01-01 |
| AU5469396A (en) | 1997-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1010116A1 (en) | Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising them | |
| ZA9810490B (en) | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor | |
| HUP9700328A3 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
| HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
| HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| ZA9510146B (en) | Novel perhydroisoindole derivatives processes for their preparation and pharmaceutical compositions comprising them | |
| IL123861A0 (en) | Phenylacetic acid derivatives processes and intermediates for their preparation and compositions comprising them | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| IL112589A (en) | Polysubstituted-3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives process and novel intermediates for their preparation and pharmaceutical compositions containing them | |
| ZA9557B (en) | Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them | |
| IL124768A0 (en) | Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents | |
| HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
| HUP9802393A3 (en) | Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates | |
| IL123900A0 (en) | New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions | |
| IL117495A0 (en) | Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| NZ291597A (en) | Carboxycyclopropan-1-yl derivatives, preparation, pharmaceutical compositions and intermediates thereof | |
| HU9600320D0 (en) | Process and new intermediates for the preparation of triazolinon-derivatives | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them | |
| GB9518553D0 (en) | New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same | |
| IL119603A (en) | Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP9900079A3 (en) | 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
| HUP9601712A3 (en) | Substituted benzothiazine derivatives, intermediates of them, process for their preparation and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PE | Patent expired |
Effective date: 20160603 |